ReviewJournal of epidemiology and global health2026
Brucellosis in the One Health Context: Gaps in Diagnosis, Control, and Global Epidemiology.
Review in Journal of epidemiology and global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBrucellosis is a neglected zoonotic infection with persistent transmission in many endemic regions despite long-standing control efforts. Limitations in diagnosis, fragmented surveillance systems, and inconsistent implementation of control measures continue to hinder effective disease management. The objective is to critically examine current gaps in the diagnosis, global and regional epidemiology, and control of brucellosis within a One Health framework.
methodsA structured narrative review was conducted using PubMed, Scopus, and Web of Science. Peer-reviewed articles, reviews, and relevant reports published in English were screened using predefined keywords related to brucellosis, diagnosis, epidemiology, treatment, and control. Studies were selected based on relevance to human and animal disease, diagnostic approaches, and public health implications. Data were synthesized qualitatively with emphasis on diagnostic limitations, surveillance gaps, and intersectoral challenges.
resultsEvidence indicates that brucellosis remains underdiagnosed and underreported globally, particularly in low- and middle-income countries. Serological assays, although widely used, are limited by cross-reactivity and variable performance, while culture and molecular methods face constraints related to biosafety, cost, and accessibility. Marked regional heterogeneity reflects differences in veterinary infrastructure, food safety practices, and surveillance capacity. Inadequate integration between human and animal health sectors continues to undermine control efforts.
conclusionsPersistent gaps in diagnostics, surveillance, and coordinated control strategies contribute to ongoing transmission of brucellosis. Strengthening One Health approaches, improving access to standardized diagnostic tools, and enhancing surveillance systems are essential for reducing the global burden of disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.